Project description
New technology to speed up stroke diagnosis
Funded by the European Innovation Council, the Deepstroke-Acc project will support Spanish company Methinks' vision to provide universal and timely diagnosis for life-saving treatments worldwide. The first focus will be on stroke, the number one cause of disability and second cause of death globally. The company is developing the CE Mark AI product, which will accelerate time-to-treatment in any hospital based on the simplest medical imaging method (non-contrast CT scan). Deepstroke-Acc will help further optimise the technology, continue the certification process, and validate the product in different hospitals around the world.
Objective
Methinks aims at revolutionising stroke diagnosis by empowering any hospital in the world to evaluate at any time all treatments options. Today, this is only possible using advanced medical imaging, which is available in around 50% of the hospitals. Methinks will do it with standard medical imaging, which is available 24/7 in any hospital also in rural areas and less developed countries. It leads to a reduction of time-to-treatment of up to 60 minutes: In stroke, “time is brain”, i.e. every minute counts and means that the patient can talk, walk, have cognitive capabilities… and live. It will also open a huge market opportunity, since our technology can run in all small, mid and major hospitals around the world.
Bypassing advanced medical imaging is a paradigm shift that requires a large and expensive clinical trial. That is why we are considered as a high-risk company by VCs, needing the support of the EIC Accelerator. With the EIC support, we have the team to make that shift real.
Fields of science
Keywords
Programme(s)
- HORIZON.3.1 - The European Innovation Council (EIC) Main Programme
Funding Scheme
HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended FinanceCoordinator
08039 BARCELONA
Spain
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.